Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of Fraxiparine vs Clexane in Healthy Volunteers
NCT03841396Phase 4Completed
- Start
- Jun 2016
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 4 trial of nadroparin in venous thromboembolism (VTE). Started Jun 2016; status: completed.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03841396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841396.